Intracranial Drug Self-administration

颅内药物自我给药

基本信息

项目摘要

Major goal of the present project is to characterize chemical reinforcement circuitry in the brain, with the use of intracranial self-administration procedures. In the past year, we conducted three major studies. First, we have found that GABAergic receptors in the supramammillary nucleus of the posterior hypothalamus play important roles in primary reinforcement. Rats will learn to self-administer the GABA-A receptor antagonist picrotoxin or bicuculline into the supramammillary nucleus, suggesting that the supramammillary nucleus is part of reward circuitry. Secondly, we examined precise sites of reinforcement action of nicotine in and around the ventral tegmental area (VTA). We found that rats learn to self-administer nicotine into the posterior VTA, central linear nucleus, and supramammillary nucleus, whereas they do not readily learn to self-administer nicotine into regions lying between and around these regions including the anterior VTA, substantia nigra, the region just dorsal to the posterior VTA, interpeduncular nucleus, or medial mammillary nucleus. Thus, nicotine reinforcement involves multiple regions in and around the VTA. Thirdly, we have obtained results suggesting that the current division of the ventral striatum into the accumbens core and shell and the olfactory tubercle does not reflect the functional organization for amphetamine reward. Rats quickly learn to self-administer D-amphetamine into the medial shell or medial tubercle, while they do not readily learn to do so into the accumbens core, ventral shell, or lateral tubercle. Our results suggest that primary reinforcement of amphetamine is mediated via the medial portion of the ventral striatum. Thus, the medial shell and medial tubercle are more functionally related than the medial and ventral shell or the medial and lateral tubercle. The current core-shell-tubercle scheme should be reconsidered in light of recent anatomical data and these functional findings. These findings provide important information as to how the brain is organized with respect to primary reinforcement.
本项目的主要目标是利用颅内自我给药程序来表征大脑中的化学强化回路。在过去一年,我们进行了三项主要研究。首先,我们发现下丘脑后乳头体上核的GABA能受体在初级强化中起重要作用。大鼠将学会自我管理GABA-A受体拮抗剂印防己毒素或荷包牡丹碱进入乳头上核,这表明乳头上核是奖励回路的一部分。其次,我们研究了尼古丁在腹侧被盖区(VTA)及其周围的强化作用的精确部位。我们发现,大鼠学会了自我管理尼古丁进入后腹侧被盖区,中央线性核,和乳头体上核,而他们不容易学会自我管理尼古丁进入这些区域之间和周围的区域,包括前腹侧被盖区,黑质,背侧的区域刚刚到后腹侧被盖区,脚间核,或内侧乳头体核。因此,尼古丁强化涉及腹侧被盖区及其周围的多个区域。第三,我们已经得到的结果表明,目前的腹侧纹状体划分成杏仁核和壳和嗅结节并不反映安非他明奖励的功能组织。大鼠很快学会将D-苯丙胺自我注射到内侧壳或内侧结节中,而它们不容易学会将D-苯丙胺注射到腹侧壳或外侧结节中。我们的研究结果表明,安非他明的主要加强介导的腹侧纹状体的内侧部分。因此,内侧壳和内侧结节比内侧壳和腹侧壳或内侧结节和外侧结节在功能上更相关。根据最近的解剖学数据和这些功能发现,应重新考虑目前的核-壳-结节方案。这些发现提供了关于大脑如何组织初级强化的重要信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATOSHI IKEMOTO其他文献

SATOSHI IKEMOTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATOSHI IKEMOTO', 18)}}的其他基金

Histological analyses of reinforcement circuitry
强化电路的组织学分析
  • 批准号:
    7321127
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Intracranial Drug Self-administration
颅内药物自我给药
  • 批准号:
    7966803
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Correlates of motivation and reward
动机和奖励的相关性
  • 批准号:
    10699655
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Histological analyses of reinforcement circuitry
强化电路的组织学分析
  • 批准号:
    8148527
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Intracranial Drug Self-administration
颅内药物自我给药
  • 批准号:
    8736723
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Correlates of motivation and reward
动机和奖励的相关性
  • 批准号:
    8336493
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Correlates of motivation and reward
动机和奖励的相关性
  • 批准号:
    8933849
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Intracranial Drug Self-administration
颅内药物自我给药
  • 批准号:
    7593269
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Correlates of motivation and reward
动机和奖励的相关性
  • 批准号:
    10931290
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Intracranial Drug Self-administration
颅内药物自我给药
  • 批准号:
    8148511
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The role of nigrostriatal and striatal cell subtype signaling in behavioral impairments related to schizophrenia
黑质纹状体和纹状体细胞亚型信号传导在精神分裂症相关行为障碍中的作用
  • 批准号:
    10751224
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Brain Development after Early-Life Antipsychotic Treatment
早期抗精神病治疗后的大脑发育
  • 批准号:
    10629613
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
MDMA as a Treatment for Social Deficits in Schizophrenia
MDMA 作为精神分裂症社交缺陷的治疗方法
  • 批准号:
    10696852
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Neural Substrates Controlling Metabolic and Reproductive State
控制代谢和生殖状态的神经基质
  • 批准号:
    10709217
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
IND-enabling studies for cell therapy in Parkinson's disease
帕金森病细胞疗法的 IND 研究
  • 批准号:
    10760861
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
DREADD Manipulations of Drug Choice
药物选择的可怕操纵
  • 批准号:
    10574862
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Aberrant dopamine system function in a rodent model of perimenopause: relevance to psychosis
围绝经期啮齿动物模型中多巴胺系统功能异常:与精神病的相关性
  • 批准号:
    10585490
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Dopaminergic control of obesity in mice
多巴胺能控制小鼠肥胖
  • 批准号:
    10718973
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Molecular target and circuitry underlying the preclinical effects of psychedelics in models of opioid use disorder
阿片类药物使用障碍模型中迷幻药临床前作用的分子靶点和电路
  • 批准号:
    10751173
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Uptake2 transporters: Novel sex-dependent molecular targets to treat stimulant use disorder
Uptake2转运蛋白:治疗兴奋剂使用障碍的新型性别依赖性分子靶标
  • 批准号:
    10595444
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了